Meister A, Griffith O W, Novogrodsky A, Tate S S
Ciba Found Symp. 1979(72):135-61. doi: 10.1002/9780470720554.ch9.
An appreciable fraction of the sulphur present in the mammal occurs in the form of glutathione, whose concentration in various tissues ranges from about 0.8 to about 8 mM; the extracellular concentration of glutatione (largely present as the disulphide) is in the micromolecular range. The synthesis of glutathione and its utilization take place by the reactions of the gamma-glutamyl cycle, which include those catalysed by gamma-glutamylcysteine and glutathione synthetases, gamma-glutamyl transpeptidase, cysteinylglycinase, gamma-glutamyl cyclotransferease, and 5-oxoprolinase. gamma-Glutamyl transpeptidase catalyses transpeptidation (with amino acids and dipeptides) and hydrolysis reactions with both blutathione and its disulphide. The transpeptidase is membrane-boudn, apparently to the outer surface of the cell, and is found in certain epithelial cells in anatomical sites that are involved in transport and secretory activities (e.g., renal tubule, jejunal villi, choroid plexus, ciliary body). Evidence that the reactions of the gamma-glutamyl cycle take place in vivo has come from studies with labelled metabolites and selective enzyme inhibitors, and on inborn errors of metabolism associated with specific enzyme deficiencies. Inhibition in vivo of gamma-glutamyl cyclotransferase and 5-oxoprolinase leads, respectively, to decreased and increased renal levels of 5-oxoproline. Administration of a specific inhibitor of gamma-glutamylcysteine synthetase, such as buthionine sulphoximine, leads to a rapid decline in the glutamylcysteine synthetase, such as buthionine sulphoximine, leads to a rapid decline in the glutathione level of the kidney and other tissues, reflecting the appreciable rate of glutathione utilization. When gamma-glutamyl transpeptidase is inhibited in vivo by injection of L- or D-gamma-glutamyl-(o-carboxy)phenylhydrazide, there is extensive glutathionuria and the blood plasma level of glutathione increases. Studies in which inhibitors of glutathione synthesis and transpeptidation were given to mice showed that transport of intracellular glutathione to membrane-bound transpeptidase is a discrete step in the gamma-glutamyl cycle, and that the level of plasma glutatione reflects (a) synthesis of glutathione and its export by liver, muscle, and other tissues and (b) utilization of glutatione by kidney and other tissues. Studies on several lymphoid cell lines show that these cells also actively translocate glutathione out of the cell. A summary scheme is given for the metabolism of glutathione in which glutathione is translocated to the cell membrane where it may be utilized as such or oxidized to glutathione disulphide. Oxidation is inhibited, and transpeptidation is promoted by the presence of amino acids that are substrates of the transpeptidase. Glutathione exported from cells that have membrane-bound transpeptidase may be recovered by the cell transport of gamma-glutamyl amino acids and free amino acids...
哺乳动物体内相当一部分硫以谷胱甘肽的形式存在,其在各种组织中的浓度范围约为0.8至8 mM;细胞外谷胱甘肽(主要以二硫化物形式存在)的浓度处于微分子范围。谷胱甘肽的合成及其利用通过γ-谷氨酰循环的反应进行,该循环包括由γ-谷氨酰半胱氨酸和谷胱甘肽合成酶、γ-谷氨酰转肽酶、半胱氨酰甘氨酸酶、γ-谷氨酰环化转移酶和5-氧脯氨酸酶催化的反应。γ-谷氨酰转肽酶催化转肽反应(与氨基酸和二肽)以及谷胱甘肽及其二硫化物的水解反应。转肽酶是膜结合的,显然位于细胞外表面,存在于参与转运和分泌活动的解剖部位的某些上皮细胞中(例如肾小管、空肠绒毛、脉络丛、睫状体)。γ-谷氨酰循环反应在体内发生的证据来自对标记代谢物和选择性酶抑制剂的研究,以及与特定酶缺陷相关的先天性代谢错误的研究。体内抑制γ-谷氨酰环化转移酶和5-氧脯氨酸酶分别导致肾脏中5-氧脯氨酸水平降低和升高。给予γ-谷氨酰半胱氨酸合成酶的特异性抑制剂,如丁硫氨酸亚砜胺,会导致肾脏和其他组织中谷胱甘肽水平迅速下降,这反映了谷胱甘肽的可观利用速率。当通过注射L-或D-γ-谷氨酰-(邻羧基)苯肼在体内抑制γ-谷氨酰转肽酶时,会出现大量谷胱甘肽尿,血浆中谷胱甘肽水平升高。对小鼠给予谷胱甘肽合成和转肽抑制剂的研究表明,细胞内谷胱甘肽向膜结合转肽酶的转运是γ-谷氨酰循环中的一个离散步骤,血浆谷胱甘肽水平反映了(a)肝脏、肌肉和其他组织中谷胱甘肽的合成及其输出,以及(b)肾脏和其他组织对谷胱甘肽的利用。对几种淋巴细胞系的研究表明,这些细胞也能将谷胱甘肽主动转运出细胞。给出了谷胱甘肽代谢的简要示意图,其中谷胱甘肽被转运到细胞膜,在那里它可以原样被利用或氧化为谷胱甘肽二硫化物。氧化受到抑制,转肽酶的底物氨基酸的存在促进了转肽反应。从具有膜结合转肽酶的细胞中输出的谷胱甘肽可以通过γ-谷氨酰氨基酸和游离氨基酸的细胞转运被细胞回收……